Video

Dr. Nelson on Why Patients With mCRC are Often Referred to Surgeons First

Douglas A. Nelson, MD, discusses why patients with metastatic colorectal cancer are often referred to surgeons before medical oncologists.

Douglas A. Nelson, MD, associate professor in the Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses why patients with metastatic colorectal cancer (mCRC) are often referred to surgeons before medical oncologists.

Patients with undiagnosed mCRC who are admitted to the hospital for anemia, bleeding, or pain could be referred to a surgeon before being seen by a medical oncologist, says Nelson.

In the outpatient setting, gastroenterologists may diagnose a patient with mCRC, says Nelson. However, if the patient develops an obstruction, the gastroenterologist may refer the patient to a surgeon for resection rather than to a medical oncologist.

According to Nelson, this approach is not always optimal. Certain patients should be seen by a medical oncologist prior to a surgeon.

Related Videos
Erminia Massarelli, MD, PhD, MS
Karen L. Reckamp, MD, MS
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Tanios Bekaii-Saab, MD, FACP
Moritz Fürstenau, MD
Jun Gong, MD
Thierry Facon, MD
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School